BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/21/2026 3:32:19 AM | Browse: 4 | Download: 0
 |
Received |
|
2026-02-10 01:58 |
|
Peer-Review Started |
|
2026-02-10 01:58 |
|
First Decision by Editorial Office Director |
|
2026-03-20 10:54 |
|
Return for Revision |
|
2026-03-20 10:54 |
|
Revised |
|
2026-04-11 04:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-05-18 02:48 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-18 08:52 |
|
Articles in Press |
|
2026-05-18 08:52 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-08-04 12:47 |
|
Publish the Manuscript Online |
|
2026-08-21 03:32 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Evidence Review |
| Article Title |
Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jorge Gutiérrez-Cuevas, Ana Sandoval-Rodriguez, Jesús Garcia-Bañuelos, Marcelo Heron Petri and Juan Armendariz-Borunda |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Mexico |
No. CF-2023-I-473 |
|
| Corresponding Author |
Jorge Gutiérrez-Cuevas, PhD, Professor, Department of Molecular Biology and Genomics, Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, 950 Sierra Mojada Street, Guadalajara 44340, Jalisco, Mexico. gutierrezcj05@gmail.com |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Diagnostic criteria; Cardiometabolic comorbidities; Insulin resistance; Systemic inflammation; Oxidative stress; Endothelial dysfunction; Cardiovascular disease; Therapeutic strategies |
| Core Tip |
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic liver disease, mostly prevalent in Latin America, associated with the development of cardiovascular disease (CVD). Its management and treatment can be challenging, especially in advanced stages (fibrosis and cirrhosis); thus, this disease should be treated by a multidisciplinary team of hepatologists, cardiologists, and nutritionists (among others) in order to reduce liver-related and cardiovascular risk factors. This comprehensive review provides insight into the clinical evidence of the connection between MASLD and CVD through cardiometabolic risk factors. |
| Publish Date |
2026-08-21 03:32 |
| Citation |
Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Garcia-Bañuelos J, Petri MH, Armendariz-Borunda J. Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease. World J Gastroenterol 2026; 32(35): 119898
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i35/119898.htm |
| DOI |
https://doi.org/10.3748/wjg.119898 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
